Julien's Primer of Drug Action

Product Description

The fourteenth edition includes new research on and coverage of: the scope of the opioid epidemic in the United States, and new drugs used to treat opioid dependence and opioid overdose; therapeutic uses of drugs commonly characterized as recreational, including marijuana to treat Alzheimer's, PTSD, and epilepsy; hallucinogenics for the treatment of multiple psychiatric disorders; and ketamine for the treatment of depression; Cannabidiol (CBD) and its therapeutic uses; synthetic drugs including synthetic cannabinoids (Spice and K2), fentanyl derivatives, and bath salts; smoking and mental health; the use of genetic testing to predict the efficacy of antidepressants; the effects of e-cigarettes, their use in smoking cessation, and among young people; the effects of persistent marijuana, alcohol, and stimulant use in adolescence; the efficacy of antipsychotics to treat dementia, Parkinson's, bipolar, OCD, and PTSD.--

Customers Who Bought This Item Also Bought

*If this is not the "Julien's Primer of Drug Action" product you were looking for, you can check the other results by clicking this link.  Details were last updated on Nov 22, 2024 16:48 +08.